CRP and cancer: Many studies have shown that serum inflammatory markers, such as C-reactive protein (CRP) [38–40], the NLR [41–43], the platelet-to-lymphocyte ratio [44, 45], the Glasgow Prognostic Score (GPS) [46, 47], and the systemic immune-inflammation index [48, 49], are related to the clinical outcomes of cancer patients.